Archive - YXJM Finance Hub

Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1

Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1

Citizens Lowers MiMedx Group, Inc. (MDXG) Valuation to $7 Amid Sluggish Recovery Trends

Citizens Lowers MiMedx Group, Inc. (MDXG) Valuation to $7 Amid Sluggish Recovery Trends

ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slightly as RBC Flags Seasonal Biotech Headwinds

ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slightly as RBC Flags Seasonal Biotech Headwinds

RBC Cuts Galapagos NV (GLPG) Price Target to $28, Maintains Sector Perform Ahead of Q1

RBC Cuts Galapagos NV (GLPG) Price Target to $28, Maintains Sector Perform Ahead of Q1

Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead

Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead

ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access With First Commercial Use in Saudi Arabia

ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access With First Commercial Use in Saudi Arabia

BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models

BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models

Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib

Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib

ADMA Biologics, Inc. (ADMA) Initiated at Buy as Canaccord Cites Improving Revenue and Margin Trends

ADMA Biologics, Inc. (ADMA) Initiated at Buy as Canaccord Cites Improving Revenue and Margin Trends

Genmab A/S (GMAB) Rating Lifted by Goldman Sachs on Strong 2026 Catalyst Outlook

Genmab A/S (GMAB) Rating Lifted by Goldman Sachs on Strong 2026 Catalyst Outlook

Latest

Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1

Inspire Medical Systems, Inc. (INSP) PT Reduced to...

3 weeks ago 14

Citizens Lowers MiMedx Group, Inc. (MDXG) Valuation to $7 Amid Sluggish Recovery Trends

Citizens Lowers MiMedx Group, Inc. (MDXG) Valuatio...

3 weeks ago 13

ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slightly as RBC Flags Seasonal Biotech Headwinds

ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slig...

3 weeks ago 16

RBC Cuts Galapagos NV (GLPG) Price Target to $28, Maintains Sector Perform Ahead of Q1

RBC Cuts Galapagos NV (GLPG) Price Target to $28, ...

3 weeks ago 18

Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead

Novavax, Inc. (NVAX) PT Increased as B. Riley Sees...

3 weeks ago 18

ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access With First Commercial Use in Saudi Arabia

ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access Wi...

3 weeks ago 16

BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models

BioNTech SE (BNTX) PT Slightly Raised as Morgan St...

3 weeks ago 17

Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib

Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at...

3 weeks ago 16

ADMA Biologics, Inc. (ADMA) Initiated at Buy as Canaccord Cites Improving Revenue and Margin Trends

ADMA Biologics, Inc. (ADMA) Initiated at Buy as Ca...

3 weeks ago 16

Genmab A/S (GMAB) Rating Lifted by Goldman Sachs on Strong 2026 Catalyst Outlook

Genmab A/S (GMAB) Rating Lifted by Goldman Sachs o...

3 weeks ago 14

FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)’s KT-621 for Eosinophilic Asthma

FDA Grants Fast Track Designation to Kymera Therap...

3 weeks ago 16

IDEAYA Biosciences, Inc. (IDYA) PT Increased as Wedbush Highlights Positive OptimUM-02 Trial Readout

IDEAYA Biosciences, Inc. (IDYA) PT Increased as We...

3 weeks ago 17

Caris Life Sciences, Inc. (CAI) Coverage Begins at Neutral as Piper Cites Need for Growth Acceleration

Caris Life Sciences, Inc. (CAI) Coverage Begins at...

3 weeks ago 15

Vertex Pharmaceuticals Incorporated (VRTX) PT Nudged Higher as RBC Updates Biotech Sector Outlook

Vertex Pharmaceuticals Incorporated (VRTX) PT Nudg...

3 weeks ago 17

Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models

Insmed Incorporated (INSM) PT Lifted to $230 as Gu...

3 weeks ago 17

Here’s Why Crescent Energy (CRGY) Soared in Q1

Here’s Why Crescent Energy (CRGY) Soared in Q1

3 weeks ago 18

Riot Platforms Sells Another 500 Bitcoin

Riot Platforms Sells Another 500 Bitcoin

3 weeks ago 20

Microsoft will reportedly invite 7% of their US wo...

3 weeks ago 16